| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2019-11-19 | ETF MANAGERS GROUP, LLC | Insys Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-04-29 | ETF MANAGERS GROUP, LLC | Insys Therapeutics, Inc. | 6,920,536 | 9.3% | EDGAR |
| SC 13G/A | 2019-03-07 | ETF MANAGERS GROUP, LLC | Insys Therapeutics, Inc. | 5,976,671 | 8.0% | EDGAR |
| SC 13G/A | 2019-02-26 | ETF MANAGERS GROUP, LLC | Insys Therapeutics, Inc. | 4,824,874 | 6.5% | EDGAR |
| SC 13G | 2019-02-19 | ETF MANAGERS GROUP, LLC | Insys Therapeutics, Inc. | 3,740,852 | 5.0% | EDGAR |
| SC 13G/A | 2019-02-13 | ORBIMED ADVISORS LLC | Insys Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D | 2018-03-08 | Insys Therapeutics, Inc. Voting Trust | Insys Therapeutics, Inc. | 42,536,080 | 58.0% | EDGAR |
| SC 13G/A | 2018-02-13 | ORBIMED ADVISORS LLC | Insys Therapeutics, Inc. | 2,914,000 | 4.0% | EDGAR |
| SC 13G/A | 2017-02-13 | ORBIMED ADVISORS LLC | Insys Therapeutics, Inc. | 2,538,600 | 3.5% | EDGAR |
| SC 13G/A | 2017-02-10 | SCOPIA CAPITAL MANAGEMENT LP | Insys Therapeutics, Inc. | 2,806,620 | 3.9% | EDGAR |
| SC 13G/A | 2016-03-10 | SCOPIA CAPITAL MANAGEMENT LP | Insys Therapeutics, Inc. | 7,434,936 | 10.4% | EDGAR |
| SC 13G/A | 2016-02-16 | JANUS CAPITAL MANAGEMENT LLC | Insys Therapeutics, Inc. | 2,955,965 | 4.1% | EDGAR |
| SC 13G | 2016-02-16 | SCOPIA CAPITAL MANAGEMENT LP | Insys Therapeutics, Inc. | 5,824,085 | 8.1% | EDGAR |
| SC 13G | 2016-02-12 | ORBIMED ADVISORS LLC | Insys Therapeutics, Inc. | 1,563,200 | 2.2% | EDGAR |
| SC 13G | 2015-02-18 | JANUS CAPITAL MANAGEMENT LLC | Insys Therapeutics, Inc. | 1,830,899 | 5.2% | EDGAR |
| SC 13G | 2014-11-18 | KAPOOR JOHN N | Insys Therapeutics, Inc. | 21,124,805 | 61.9% | EDGAR |
| SC 13G/A | 2014-02-07 | BlackRock Inc. | Insys Therapeutics, Inc. | 1,019,381 | 4.7% | EDGAR |
| SC 13G | 2014-01-29 | BlackRock Inc. | Insys Therapeutics, Inc. | 1,084,396 | 5.0% | EDGAR |